To provide innovative solutions to Antimicrobial Resistance (AMR) by leveraging cutting-edge AI-based technology and scientific research. We aim to address the growing global healthcare issues associated with AMR and offer breakthrough solutions that significantly impact patient outcomes and public health.
To create a world free from drug-resistant infections by safeguarding the health of humans, animals, and the environment through a holistic One Health approach.
To co-develop cost-effective real-time diagnostics and sustainable therapeutics in collaboration with all stakeholders involved in combating Antimicrobial Resistance (AMR).
Chairman
Scientific Affairs
Co-Chairman
Drug Discovery
Co-Chairman
Clinical Management
Co Founder and
Director
Chief Business
Officer
Professor of
Immunology
Cornell University, USA
Life Science, Health and
Climate Consultancy,
Greater Paris, France
Head, Biosafety
BSL3 Laboratory, ICDDR
Dhaka, Bangladesh
Chief Executive Officer
Innominds Inc
SanJose, USA
